VAX-ID®, the heart of the Idevax company, is an award-winning patented drug delivery device platform suited for intradermal injection. The device can be preconfigured with a 32G needle as well as with a 27G needle to allow for different applications, with a penetration depth of 0.85 and 1.2mm respectively. The device is suited for accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances in the dermal layer of the skin of both humans and animals.
| Website | https://www.idevax.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2021 |
| Phone | +32 3 485 50 16 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Patented Technology, Drug Delivery Platform, Pharmaceutical Technology, Innovative Drug Delivery, Drug Administration, Advanced Drug Delivery, Injection Systems, Healthcare Technology, Medical Technology, Biotechnology, Therapeutic Devices, Precision Medicine |
| Competitors | Johnson & Johnson, AbbVie, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Genentech, Moderna Therapeutics, Novavax, Sanofi Pasteur +34 more (view full list) |
Looking for a particular IDEVAX employee's phone or email?
Vanessa Vankerckhoven is the CEO, Co-Founder, Director of IDEVAX.
10 people are employed at IDEVAX.